However, in a mouse model of mammary cancer, mutations in ERβ resulted in reduced infiltration of CD4+ and CD8+ T cells and lower levels of IFNγ within the tumor microenvironment, leading to tumor growth [88]. This evidence concerns the gene ESR2 and breast cancer.